Round-the-clock or start-and-stop: Does the regimen matter when dydrogesterone is used to treat chronic pelvic pain due to endometriosis?
Other
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated whether a continuous or intermittent regimen of dydrogesterone was more effective in treating chronic pelvic pain associated with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (5)
- Clinical practice. Endometriosis via openalex
- Endometriosis via openalex
- Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study via openalex
- The place of dydrogesterone in the treatment of endometriosis and adenomyosis via openalex
- Women's experiences of medical treatment for endometriosis and its impact on PRE-EMPT trial participation: a qualitative study via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:32:54.761249+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK